Northwestern Mutual Wealth Management
PLRX icon

Northwestern Mutual Wealth Management’s Pliant Therapeutics PLRX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126 Buy
+100
New +$126 ﹤0.01% 3982
2024
Q4 		– Sell
-30
Closed -$336 – 3820
2024
Q3 		$336 Buy
+30
New +$375 ﹤0.01% 3384

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Northwestern Mutual Wealth Management's PLRX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Pliant Therapeutics (PLRX) in Q1 2026: 100 shares worth $126. The stake represents ﹤0.01% of the portfolio and ranks #3982 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in PLRX as recently as Q3 2024.

Northwestern Mutual Wealth Management first reported a position in PLRX in Q3 2024 and has held it in 2 quarters since. The position peaked at $336 in Q3 2024. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 100 shares of Pliant Therapeutics worth $126 as of Q1 2026.
  • Pliant Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • Pliant Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3982 holding.
  • Northwestern Mutual Wealth Management first reported a position in Pliant Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • Northwestern Mutual Wealth Management's Pliant Therapeutics position peaked at $336 in Q3 2024.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.